ARCHIVES

FDA Approves Imaging Agent For Recurrent Prostate Cancer

This article is from The Cancer Letter archive.

Vol. 35 No. 9 | September 28, 2012

Download PDF Visit The Full Archive

Related Articles

In Brief: Lawyers Halt Reference Chemical Distribution To Grantees, Threaten To Stop Viruses, Animals

September 2, 1977

New Frederick Contract Drops Slightly From ‘75

July 11, 1975

GI Intergroup called a model for proposed scientific steering committees.

June 10, 2005

ACCC To Take In State Chapters, Forms Trials Group

April 6, 1990

NCI, NCAB o Seek $1.036 billion In ’79; Senate Committee Approves $920 Million for Fiscal ‘78

June 3, 1977

Ramucirumab Improves Overall Survival, Progression-Free Survival in Phase III Trial

October 26, 2012